DS MED LLC - 13 Apr 2022 Form 4 Insider Report for Longeveron Inc. (LGVN)

Role: 10%+ Owner
Signature: /s/ Paul T. Lehr, attorney-in-fact
Issuer symbol: LGVN
Transactions as of: 13 Apr 2022
Net transactions value: $0
Form type: 4
Filing time: 15 Apr 2022, 17:00:35 UTC
Next filing: 19 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LGVN	Common Stock	Other	$0	-748,694	-9.6%	$0.000000	7,024,208	13 Apr 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares consist of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock.
F2	Shares distributed to members of DS Med, LLC, for no consideration.

Content

Shares consist of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock.

Shares distributed to members of DS Med, LLC, for no consideration.